Plasma Protein Binding of Drugs in Pregnancy

Emilio Perucca, Antonio Crema

Research output: Contribution to journalArticle

113 Citations (Scopus)

Abstract

The degree of binding to plasma proteins is an important determinant of drug disposition and response. Normal human pregnancy is associated with considerable changes in the concentration of plasma proteins, free fatty acids and possibly other endogenous substances interfering with drug binding. The possibility of an associated change in plasma binding capacity therefore needs to be taken into consideration. Experimental studies conducted mostly in vitro have shown that the plasma protein binding of many (but not all) drugs is decreased during pregnancy, particularly during the last trimester. This phenomenon should be taken into account when interpreting serum concentrations of total (free + protein-bound) drug in clinical practice. Notable examples of drugs whose unbound fraction increases during pregnancy include diazepam, valproic acid, phenytoin, phenobarbitone, salicylic acid, pethidine, lignocaine, dexamethasone, sulphafurazole and propranolol. For many drugs, important differences have been demonstrated in the degree of protein binding between maternal and cord plasma. In some cases, this may provide an explanation for the finding of marked differences in total drug concentration between maternal and fetal plasma at the time of delivery.

Original languageEnglish
Pages (from-to)336-352
Number of pages17
JournalClinical Pharmacokinetics
Volume7
Issue number4
DOIs
Publication statusPublished - 1982

Fingerprint

Protein Binding
Blood Proteins
Pregnancy
Pharmaceutical Preparations
Mothers
Meperidine
Salicylic Acid
Third Pregnancy Trimester
Valproic Acid
Phenytoin
Phenobarbital
Diazepam
Lidocaine
Nonesterified Fatty Acids
Propranolol
Dexamethasone
Serum
Proteins

ASJC Scopus subject areas

  • Pharmacology (medical)
  • Pharmacology
  • Pharmacology, Toxicology and Pharmaceutics(all)

Cite this

Plasma Protein Binding of Drugs in Pregnancy. / Perucca, Emilio; Crema, Antonio.

In: Clinical Pharmacokinetics, Vol. 7, No. 4, 1982, p. 336-352.

Research output: Contribution to journalArticle

Perucca, Emilio ; Crema, Antonio. / Plasma Protein Binding of Drugs in Pregnancy. In: Clinical Pharmacokinetics. 1982 ; Vol. 7, No. 4. pp. 336-352.
@article{3df3fdd292eb4456bd6148ddf00af183,
title = "Plasma Protein Binding of Drugs in Pregnancy",
abstract = "The degree of binding to plasma proteins is an important determinant of drug disposition and response. Normal human pregnancy is associated with considerable changes in the concentration of plasma proteins, free fatty acids and possibly other endogenous substances interfering with drug binding. The possibility of an associated change in plasma binding capacity therefore needs to be taken into consideration. Experimental studies conducted mostly in vitro have shown that the plasma protein binding of many (but not all) drugs is decreased during pregnancy, particularly during the last trimester. This phenomenon should be taken into account when interpreting serum concentrations of total (free + protein-bound) drug in clinical practice. Notable examples of drugs whose unbound fraction increases during pregnancy include diazepam, valproic acid, phenytoin, phenobarbitone, salicylic acid, pethidine, lignocaine, dexamethasone, sulphafurazole and propranolol. For many drugs, important differences have been demonstrated in the degree of protein binding between maternal and cord plasma. In some cases, this may provide an explanation for the finding of marked differences in total drug concentration between maternal and fetal plasma at the time of delivery.",
author = "Emilio Perucca and Antonio Crema",
year = "1982",
doi = "10.2165/00003088-198207040-00004",
language = "English",
volume = "7",
pages = "336--352",
journal = "Clinical Pharmacokinetics",
issn = "0312-5963",
publisher = "Adis International Ltd",
number = "4",

}

TY - JOUR

T1 - Plasma Protein Binding of Drugs in Pregnancy

AU - Perucca, Emilio

AU - Crema, Antonio

PY - 1982

Y1 - 1982

N2 - The degree of binding to plasma proteins is an important determinant of drug disposition and response. Normal human pregnancy is associated with considerable changes in the concentration of plasma proteins, free fatty acids and possibly other endogenous substances interfering with drug binding. The possibility of an associated change in plasma binding capacity therefore needs to be taken into consideration. Experimental studies conducted mostly in vitro have shown that the plasma protein binding of many (but not all) drugs is decreased during pregnancy, particularly during the last trimester. This phenomenon should be taken into account when interpreting serum concentrations of total (free + protein-bound) drug in clinical practice. Notable examples of drugs whose unbound fraction increases during pregnancy include diazepam, valproic acid, phenytoin, phenobarbitone, salicylic acid, pethidine, lignocaine, dexamethasone, sulphafurazole and propranolol. For many drugs, important differences have been demonstrated in the degree of protein binding between maternal and cord plasma. In some cases, this may provide an explanation for the finding of marked differences in total drug concentration between maternal and fetal plasma at the time of delivery.

AB - The degree of binding to plasma proteins is an important determinant of drug disposition and response. Normal human pregnancy is associated with considerable changes in the concentration of plasma proteins, free fatty acids and possibly other endogenous substances interfering with drug binding. The possibility of an associated change in plasma binding capacity therefore needs to be taken into consideration. Experimental studies conducted mostly in vitro have shown that the plasma protein binding of many (but not all) drugs is decreased during pregnancy, particularly during the last trimester. This phenomenon should be taken into account when interpreting serum concentrations of total (free + protein-bound) drug in clinical practice. Notable examples of drugs whose unbound fraction increases during pregnancy include diazepam, valproic acid, phenytoin, phenobarbitone, salicylic acid, pethidine, lignocaine, dexamethasone, sulphafurazole and propranolol. For many drugs, important differences have been demonstrated in the degree of protein binding between maternal and cord plasma. In some cases, this may provide an explanation for the finding of marked differences in total drug concentration between maternal and fetal plasma at the time of delivery.

UR - http://www.scopus.com/inward/record.url?scp=0020318252&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0020318252&partnerID=8YFLogxK

U2 - 10.2165/00003088-198207040-00004

DO - 10.2165/00003088-198207040-00004

M3 - Article

C2 - 6749369

AN - SCOPUS:0020318252

VL - 7

SP - 336

EP - 352

JO - Clinical Pharmacokinetics

JF - Clinical Pharmacokinetics

SN - 0312-5963

IS - 4

ER -